Amphotericin B Encapsulated in Liposomes Administered to Cancer Patients

Annals of the New York Academy of Sciences

Volumn 544, Issue 1, 1988, Pages 598-610

  MEUNIER, F ^a   SCULIER, J P ^a   COUNE, A ^a   BRASSINNE, C ^a   HEYMAN, C ^a   LADURON, C ^a   COLLETTE, N ^a   HOLLAERT, C ^a   BRON, D ^a   KLASTERSKY, J ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; DRUG CARRIER; LIPOSOME;

ADULT; ANTIFUNGAL ACTIVITY; CANDIDA ALBICANS; CLINICAL ARTICLE; DRUG ADMINISTRATION; DRUG TOXICITY; FEMALE; FOLLOW UP; FUNGUS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MYCOSIS; NONHUMAN; PRIORITY JOURNAL;

ADULT; AGED; AMPHOTERICIN B; ASPERGILLOSIS; CANDIDIASIS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMAN; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, NONLYMPHOCYTIC, ACUTE; LIPOSOMES; LUNG NEOPLASMS; MALE; MIDDLE AGE; PHOSPHOLIPIDS; SUPPORT, NON-U.S. GOV'T;

EID: 0024160529     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1988.tb40460.x     Document Type: Article

References (24)

1. Fungal infections in the compromised host
2. Newer antifungal agents and their use, including an update on amphotericin B and flucytosine
3. Antifungal agents
4. Treatment of opportunistic mycoses in the immunosuppressed patient
5. New lives for old drugs: Liposomal drug delivery systems reduce the toxicity but not the potency of certain chemotherapeutic agents
6. Lamellar systems for drug solubilization
7. Liposomes as carriers of antimicrobial agents
8. Intravenous administration of a water‐insoluble antimitotic compound entrapped in liposomes: Preliminary report on infusion of large volumes of liposomes to man
9. Intravenous infusion of high doses of liposomes containing NSC 251635, a water‐insoluble cytostatic agent: A pilot study with pharmacokinetic data
10. Pilot study of amphotericin B entrapped into sonicated liposomes in cancer patients with fungal infections
11. High‐performance liquid chromatographic determination of amphotericin B in human serum
12. Serum fungistatic and fungicidal activity in volunteers receiving antifungal agents
13. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: A preliminary study
14. Treatment of hepatosplenic fungal infections with liposomal amphotericin B
15. Renal tubular acidosis due to amphotericin B
16. Nephrotoxic effects of amphotericin B, including renal tubular acidosis
17. Defect in urinary acidification induced in vitro by amphotericin B
18. Renal tubular acidosis
19. Nephrotoxicity of amphotericin B, with emphasis on changes in tubular function
20. Leukoencephalopathy in patients treated with amphotericin B methyl ester
21. In vitro antifungal activities of amphotericin B and liposome‐encapsulated amphotericin B. Antimicrob